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SUMMARY
Chromosomal mosaicism is one of the most vexing problems for clinical cytogenetic laboratories and
personnel time used for analysis at the microscope is one of the principle costs in cytogenetic laborato-
ries. We use data collected from 26 cytogenetic laboratories to evaluate whether the American College
of Medical Genetics guidelines for minimum number of cells to count to exclude mosaicism in amni-
otic uid specimens is appropriate. An accurate estimate of the number of mosaics that are missed by
current cell counting practices is an important step in this process. Thus, we present a new method for
estimating the number of mosaics that are missed and we use computer simulation to evaluate this new
method. Our results indicate that if the clinical signicance of mosaicism is suspected to be minimal
for certain cytogenetic anomalies when the percentage of abnormal cells is 15 per cent or less, then it
may be sucient to use a 15-cell counting-rule-for-detection along with a minimum total cell count of
30 regardless of whether abnormal cells or normal cells are in the minority. Published in 2005 by John
Wiley & Sons, Ltd.
KEY WORDS: binomial distribution; cytogenetics; mosaicism; mosaic heterogeneity
INTRODUCTION
In cytogenetics, when an individual has two or more cell lines with diering chromosomal
constituents, the individual is referred to as a mosaic. Detection of a mosaic case is determined
by counting a specied number of cells. Hook [1] published tables indicating the number of
cells that must be counted to exclude a specied percent mosaicism with 90, 95, and 99 per
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cent condence. His tables are based on binomial sampling theory applied to the problem
of mosaic case identication. Since the proportion of abnormal cells varies greatly among
mosaics, the likelihood of actually detecting a mosaic case depends upon each individual’s
true percent mosaicism and upon the number of cells counted to exclude mosaicism [1].
Thus, even when a constant number of cells to exclude mosaicism is counted in each subject
sample, the error in estimates of the true numbers of mosaic cases (among the total number of
subject samples tested) will depend upon the range of mosaic percentages among case subjects.
Additional sources of error can result if a dierent number of cells to exclude mosaicism is
counted in each sample or if a dierent total number of cells is counted.
One purpose of the CYTO2000 initiative [2, 3] was to use data collected from clinical cyto-
genetic laboratories to consider whether the American College of Medical Genetics (ACMG)
guidelines [4] for minimum number of cells to count to exclude mosaicism in amniotic uid
specimens is appropriate. For the in situ technique, these guidelines recommend counting ‘a
minimum of 15 cells from at least 15 colonies (10 cells if 15 are not available), distributed
as equally as possible between at least two independently established cultures’. Type 3 (or
true) mosaicism ‘occurs when two or more cell lines are in separate cultures from a sample
and all cell lines must have two or more cells with the same karyotype. Mosaicism is rst
suspected upon detection of a cell with a dierent karyotype than the rst line. Mosaicism
is not conrmed until another cell with the second karyotype is observed’ [3]. If no new
karyotype (i.e. a cell diering from the rst cell examined) is detected once the counting-
rule-for-detection (15 cells from 15 colonies) has been reached, counting is stopped and the
sample is considered non-mosaic. If at least one cell with a new karyotype is detected by the
counting-rule-for-detection, counting continues. For the sample to be considered a conrmed
mosaic case, at least 2 cells (i.e. one more cell than is required for detection) with the same
karyotype must be detected.
In the rst CYTO2000 study [3] of amniotic uid mosaic cases collected from 26 cyto-
genetic laboratories, simple calculations based on binomial theory were used to estimate the
true number of cases represented by the subset of cases (n=433) detected by the 15th cell
counted. In that paper, the estimate of the true number of cases was based on the probabil-
ity of detection (rather than detection and conrmation) of the second cell line. Thus, the
numbers of missed cases were underestimated (especially when the percent mosaicism was
low) because the estimation method assumed that all detected cases were used, whereas only
cases detected and conrmed were used; and because the joint probability of detection and
conrmation is never larger than the probability of detection. In this paper, we describe and
evaluate an improved method for estimating the true number of cases based on the joint prob-
ability of detection by the K th counted cell and conrmation by the M th counted cell, where
K is the number of cells counted to exclude mosaicism and M is the total number of cells
counted. We use computer simulation (see Appendix) to evaluate the accuracy of estimates
obtained by this new method. Finally, we use our estimates of the numbers of missed mosaic
cases to evaluate current cell counting practices (which are based on the ACMG guidelines).
MATERIALS AND METHODS
We examine the data set presented in the rst CYTO2000 study [3] of amniotic uid mosaic
cases. This data set consists of 442 cases with two cell lines detected by in situ methods in
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Table I. Simulation results for percentage error in an estimate of the true number of cases by per cent
mosaicism and total cell count. A 15-cell counting-rule-for-detection was used for mosaic case detection.
Percentage error in estimate of true number of cases
Percent mosaicism∗ True number of cases 20† 30 40
¿0–10 50 −27.7 −11.7 −3.7
¿10–15 50 −6.0 0.5 1.6
¿15–20 50 0.6 1.2 1.4
¿20–30 50 0.3 0.6 0.6
¿30–40 50 −0.2 −0.1 −0.1
¿40–50 50 −0.0 −0.0 −0.0
∗Percentages of abnormal cells above 50 per cent are translated into mosaic percentages by subtraction from
100 per cent.
†The numbers 20, 30, and 40 are the total cell counts.
26 cytogenetic laboratories. Since it was not possible to determine (for each case) the actual
number of cells counted to exclude mosaicism, we assume that a minimum of 15 cells from
15 colonies in at least two cultures were counted for in situ cultures as recommended by the
ACMG guidelines [4]. According to this counting rule, which we will refer to as a 15-cell
‘counting-rule-for-detection,’ if 15 cells=colonies are counted and no evidence of mosaicism
is detected, the analysis is stopped.
To evaluate the new method for estimating the true number of cases we assumed: (1)
that the proportion of abnormal cells in culture accurately reects the proportion of abnormal
cells in amniotic uid, (2) colonies that grow from cells in amniotic uid can be considered
independent, (3) cells examined represent a random sample of all cells that could have been
scored, and (4) there is a minimum total number of cells a cytogeneticist will count before
discontinuing pursuit of conrmation of suspected cases.
We approached the mosaic case detection problem in terms of both percentage (or pro-
portion) of abnormal cells and percent mosaicism. (Note: The percentage of abnormal cells
can range from 0 to 100 per cent, whereas the percent mosaicism can only range from 0
to 50 per cent, since any percentage of abnormal cells that exceeds 50 per cent corresponds
to a percentage of normal cells that is less than 50 per cent.) Considering only percent mo-
saicism would have precluded evaluation of whether cytogeneticists are likely to count more
cells=colonies when abnormal cells are in the minority than when normal cells are in the
minority and whether they are in turn less likely to miss low-level mosaics that are predom-
inantly normal rather than those that are predominantly abnormal. By distinguishing between
these two types of mosaics, we were able to focus attention on missed cases that are more
likely to be clinically signicant due to counting too few cells.
Cases were stratied based on observed percentage abnormal to minimize errors caused by
variation in the percentage of abnormal cells among individuals. The percent abnormal strata
chosen (see Tables I and II) correspond to the percent mosaicism strata used in the rst
CYTO2000 study [3]. A description of the method for estimating the true number of cases
follows:
The total number of mosaic cases in each stratum is estimated by forming the ratio of the
number of conrmed cases to the joint probability of case detection and conrmation based
on a minimum count of K cells to exclude mosaicism and a total count of M cells. Thus
Published in 2005 by John Wiley & Sons, Ltd. Statist. Med. 2005; 24:615–622
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Table II. Observed and estimated number of mosaic cases detected from in situ cultures by
percent mosaicism and type of cell.
Observed number of
cases detected
Percent Type of cell Estimated true number Estimated percentage
mosaicism in minority∗ By 15th cell† Total‡ of mosaic cases§ of missed cases
¿0–10 Abnormal 44 45 75 44
Normal 7 9 22
abn1=abn2 2 3 4
¿10–15 Abnormal 45 47 53 15
Normal 8 8 12
abn1=abn2 5 6 7
¿15–20 Abnormal 51 52 55 8
Normal 8 8 9
abn1=abn2 9 9 11
¿20–30 Abnormal 61 61 62 3
Normal 19 19 20
abn1=abn2 9 9 10
¿30–40 Abnormal 48 48 49 2
Normal 33 34 34
abn1=abn2 16 16 17
¿40–50 Abnormal 45 45 46 4
Normal 16 16 17
abn1=abn2 7 7 8
Total 433 442 511 14
∗abn1=abn2 refers to mosaic cases in which two dierent types of abnormal cells were detected,
but no normal cells were detected.
†Number of mosaic cases detected by the 15th cell counted from in situ cultures.
‡Total number of mosaic cases detected from in situ cultures.
§The expected true number of mosaic cases is based on the assumption that a constant 15-cell
counting-rule-for-detection was used for all cases. The total number of cells counted is assumed
to be equal to the median of the total number of cells counted for all conrmed cases in the
stratum. Further adjustments were made to the estimates when the percent mosaicism was less
than 15 per cent to account for the expected error in estimation as indicated in Table I.
assuming that detected cases are based on a constant counting-rule-for-detection of K cells
and a total count of M cells, the expected true number of cases in the ith stratum, can be
estimated by
NT =Ndc(K)=[1− (1− Pabn)K − PKabn − KPabn(1− Pabn)(M−1) − KP(M−1)abn (1− Pabn)] (1)
where Ndc(K) is the actual number of mosaic cases detected by the K th cell counted and
conrmed by the M th counted cell for stratum i, Pabn is the observed median proportion
of abnormal cells detected and conrmed for stratum i, and M is the total number of cells
counted.
Simulation: To evaluate the new estimation method, we simulated cases and non-cases
with percentages of abnormal cells within each of six strata corresponding to the six strata
used in the rst CYTO2000 study [3]. These mosaic strata are dened as follows: (0–10];
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(10–15]; (15–20]; (20–30]; (30–40]; and (40–50], where brackets indicate inclusion of the
adjacent number and parentheses indicate exclusion of the adjacent number. Percentages of
abnormal cells above 50 per cent are translated into mosaic percentages by subtraction from
100 per cent. In the simulation experiment, we used a constant counting-rule-for-detection of
15. To determine the eect of the total number of cells counted (in conrmed cases) on the
accuracy of the estimation methods we let the total cell count take values 20, 30, and 40.
(Note: an average total count of 32 cells was observed in the rst CYTO2000 study [3].) A
detailed explanation of the methods used to conduct the simulation experiment is presented
in the appendix.
RESULTS
The simulation results presented in Table I were generated using a constant counting-rule-
for-detection of 15 and total cell counts of 20, 30, or 40. The true number (50) of cases in
each stratum appears (we also performed simulations with 25 and 100 cases in each stratum;
results not shown) to have little eect on the accuracy of the estimation method. Increasing
the total cell count beyond 40 does not result in appreciable error reduction for the estimation
method, but lowering it to 20 could decrease the accuracy of the estimation method when the
per cent mosaicism is 15 per cent or less.
Table II displays actual results obtained from an analysis of 442 cases of amniotic uid
mosaicism collected from 26 cytogenetic laboratories from in situ cultures. The strata are
grouped according to percent mosaicism to facilitate comparison when abnormal cells versus
normal cells are in the minority. Also included in the table are mosaic cases in which two dif-
ferent types of abnormal cells were detected, but no normal cells were detected. The observed
numbers of detected mosaic cases in each stratum are presented along with the estimated true
numbers obtained by the new estimation method. (Note: a constant counting-rule-for detec-
tion of 15 was apparently not used for 4.5 per cent (20 of 442) of the detected cases. These
20 cases consisted of nine cases not detected until after the 15th cell was counted and 11
cases detected when fewer than 15 cells=colonies were analysed. These 20 cases were used,
however, in calculating the median percentage mosaicism for each stratum.)
Table III displays the distribution of total number of cells=colonies counted for each of the
percentage mosaicism strata. As was done in Table II, the strata are grouped according to
percent mosaicism to facilitate comparison of distributions when abnormal cells versus nor-
mal cells are in the minority. Kruskal–Wallis two-sample tests [5] to compare distributions
of total numbers of cells counted for mosaic categories with abnormal cells in the minor-
ity versus those with normal cells in the minority, suggest that cytogeneticists may tend to
count a higher total number of cells=colonies when abnormal cells are in the minority than
when normal cells are in the minority and the percent mosaicism is less than 15 per cent.
Results were also statistically signicant when the percent mosaicism was between 20 and 30
per cent.
The results discussed in the previous section raise a question about whether missed mosaics
are less likely when abnormal cells are in the minority than when they are in the majority due
to the fact that cytogeneticists tend to count a higher total number of cells when abnormal
cells are in the minority. To test this hypothesis we used the estimated true numbers of mosaic
cases (fth column of Table II) to estimate percentages of missed cases when abnormal cells
Published in 2005 by John Wiley & Sons, Ltd. Statist. Med. 2005; 24:615–622
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Table III. Distribution of total number of cells counted by percent mosaicism and type of
cell in minority.
Selected percentiles of total number of cells counted
Type of cell
Percent mosaicism in minority Min 25th Median 75th Max P∗
¿0–10 Abnormal 20 34.0 40.0 51.0 98 0.0102
Normal 10 20.0 27.0 30.0 110 2
¿10–15 Abnormal 15 21.0 30.0 38.0 81 0.0069
Normal 15 16.0 20.5 23.5 33 9
¿15–20 Abnormal 15 20.0 28.0 39.5 79 0.5067
Normal 10 20.5 23.5 32.0 40 7
¿20–30 Abnormal 15 20.0 28.0 35.0 71 0.0179
Normal 12 19.0 20.0 25.0 50 9
¿30–40 Abnormal 13 20.0 25.5 32.0 70 0.2040
Normal 13 17.0 21.0 27.0 61 0
¿40–50 Abnormal 7 19.0 21.0 29.0 100 0.1821
Normal 11 17.5 20.0 22.5 36 1
∗One degree of freedom Chi-square signicance resulting from Kruskal–Wallis two-sample tests
[5] to compare distributions of total numbers of cells counted for mosaic categories with abnormal
cells in the minority versus those with normal cells in the minority.
versus normal cells are in the minority. When the percent mosaicism is 15 per cent or less,
28 per cent (0:28= {[75 + 53] − [45 + 47]}=[75 + 53]) of cases appear to be missed when
abnormal cells are in the minority and 50 per cent (0:50= {[22 + 12] − [9 + 8]}=[22 + 12])
appear to be missed when normal cells are in the minority (p=0:01). Dierences were not
signicant when the percent mosaicism was higher than 15 per cent. These results suggest that
missed mosaics are more likely when normal cells are in the minority than when abnormal
cells are in the minority and the percent mosaicism is 15 per cent or less.
DISCUSSION AND CONCLUSIONS
In order to evaluate the American College of Medical Genetics guidelines for minimum num-
ber of cells to count to exclude mosaicism in amniotic uid cultures, an accurate estimate of
the number of mosaics that are missed by current cell counting practices must be obtained. In
this paper, we demonstrate an improved method for estimating true numbers of missed mosaic
cases that takes into account the total number of cells counted as well as the number of cells
counted to exclude mosaicism. Our method incorporates the use of data pooled from multiple
laboratories counting dierent total numbers of cells=colonies per case. When estimating true
numbers of mosaic cases, stratication of observed cases based on observed percent abnormal
cells is used to minimize error due to mosaic heterogeneity among samples.
The results of our analyses suggest (when the mosaic percentage is less than 15 per cent)
that because cytogeneticists tend to count more cells=colonies when abnormal cells are in the
minority than when normal cells are in the minority, they are more likely to miss cases with
normal cells in the minority. The curves in Figure 1, which are based on theoretic calculations
similar to those used to derive equation (1) in the Materials and Methods section, demonstrate
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Figure 1. Theoretic probability of case conrmation based on a total cell count of 20, 30, or 40 and a
counting-rule-for-detection of 15.
the relationship between true percent mosaicism and probability of case conrmation based
on a total cell count of 20, 30, or 40 and a counting-rule-for-detection of 15. These results
indicate that at least 90 per cent of cases that are 15 per cent or more mosaic will be detected
and conrmed by using a 15-cell counting-rule-for-detection along with a minimum total cell
count of 30. It is also clear that counting beyond 30 cells is not cost-eective since it will
only result in minimal gains in the numbers of conrmed cases. This observation is consistent
with the recommendation of Hsu et al. [6] when diagnosis of true mosaicism has little impact
and is not cost-eective. Thus, if future studies were to indicate, for example, that the clinical
signicance of mosaicism is suspected to be minimal for certain cytogenetic anomalies when
the percentage of abnormal cells is 15 per cent or less, then it may be sucient to use a
15-cell counting-rule-for-detection along with a minimum total cell count of 30 regardless of
whether abnormal cells or normal cells are in the minority.
APPENDIX
Each simulation experiment was accomplished (using version 6.12 of SAS) by rst generating
N sets of NC (where NC represents the total cell count and takes values 20, 30 or 40)
observations in each of six strata representing mosaic categories (1: ¿0–0:10; 2: ¿0:10–0:15;
3: ¿0:15–0:20; 4: ¿0:20–0:30; 5: ¿0:30–0:40; and 6: ¿0:40–0:50). A uniform (0,1) random
number generator was used to assign a value of 0 or 1 to each of the NC observations in each
of the N sets based on whether the uniform random number was less than or greater than the
intended mosaic proportion of the stratum. If at least one observation with the value 1 occurred
among the rst 15 of the NC observations in a set and at least one additional observation
with the value 1 occurred among the rst NC observations, then all NC observations in that
set were retained for computation of an observed percentage of abnormal cells for the case
represented by this set. If no observation with the value 1 (i.e. all of the rst 15 observations
were zeroes) occurred among the rst 15 of the NC observations in a set or if only one
Published in 2005 by John Wiley & Sons, Ltd. Statist. Med. 2005; 24:615–622
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observation with the value 1 occurred among all NC observations, then this entire set of NC
observations was dropped and, therefore, treated as a non-case or a missed case. This process
resulted in a range of observed mosaic percentages among cases within each stratum and a
variable number of observed cases in each stratum. Separately for each stratum we compared
the median number of conrmed mosaic cases to the true number of mosaic cases in the
stratum. We repeated this process 1000 times to obtain 1000 simulated data sets for each of
the six strata, each of three values of N (25, 50, and 100), and each of the three values of
NC (20, 30, 40).
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